Product Images Sevelamer Carbonate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Sevelamer Carbonate NDC 65862-930 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 3. Percentage of patients (Y-axis) attaining a phosphorus reduction from baseline (mg/dL) at least as great as the value of the X-axis. - sevelamer fig1

Figure 3. Percentage of patients (Y-axis) attaining a phosphorus reduction from baseline (mg/dL) at least as great as the value of the X-axis. - sevelamer fig1

Figure 4. Mean Phosphorus Change from Baseline for Patients who Completed 52 Weeks of Treatment - sevelamer fig2

Figure 4. Mean Phosphorus Change from Baseline for Patients who Completed 52 Weeks of Treatment - sevelamer fig2

The given text seems to be a graphical representation of the Reduction in Serum Phosphorus with Sevelamer Hydrochloride™ treatment. It shows a bar graph with the percentage of patients and their reduction from baseline. The text also mentions the term 'anesg®' and '2X,' but it is not clear what those refer to in the context of the graph. Overall, the description is regarding the graph that demonstrates the effect of Sevelamer Hydrochloride™ on the reduction of serum phosphorus levels of patients.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 0.8 g Pouch Carton - sevelamer fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 0.8 g Pouch Carton - sevelamer fig3

This appears to be a chart or graph showing some data related to the change in phosphorus levels over time in a study involving Sevelamer Hydrochloride as the active control. The numbers on the vertical axis go up to 22, and there is a percentage symbol next to the number 3. The horizontal axis is labeled "Study Week" and goes up to 52 weeks. Without more context or clearer images, it is difficult to provide a more detailed description.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2.4 g Pouch Carton - sevelamer fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2.4 g Pouch Carton - sevelamer fig4

This appears to be a medication label for Sevelamer Carbonate Oral Suspension. The medication comes in 90 pouches, each containing 0.8 grams of the drug. The medication is mixed with water and taken orally. The label includes information about dosing, storage, and manufacturer contact information. There is also mention of an orange flavor.*

sevelamer fig5

sevelamer fig5

Chemical Structure - sevelamer str

Chemical Structure - sevelamer str

This text provides a chemical structure diagram of Sevelamer Carbonate, a medication used to treat high levels of phosphorus in the blood of people with chronic kidney disease who are on dialysis. It includes a description of the various chemical groups that make up the molecule, including primary amine groups and crosslinking groups, as well as an indication of the extended polymer network present in the compound.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.